All the news Showing 7 of 7 articles from: Blood disorders (anaemia, thrombocytopenia and neutropenia)Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Low lymphocyte count a risk factor for infections for people taking HCV therapy Michael Carter / 15 January 2014 A low lymphocyte count is associated with an increased risk of infections during hepatitis C virus (HCV) treatment that includes pegylated interferon and ribavirin, according to the results of a large observational study ... One Mans Story of Working during Hepatitis C Treatment I Help C / 16 December 2013 CHMP OKs Eltrombopag for HCV Patients With Thrombocytopenia Medscape (requires registration) / 31 July 2013 HCV treatment improves survival among anemic patients Healio Infectious Diseases / 12 June 2013 Hepatitis C patients with cirrhosis respond well to boceprevir or telaprevir with careful monitoring Liz Highleyman / 05 December 2012 Real-world experience in the French early-access CUPIC cohort shows that hepatitis C patients with advanced liver damage can achieve good response to interferon-based triple-therapy including boceprevir (Victrelis) or telaprevir (Incivo), researchers reported ... Reducing ribavirin and adding EPO are both good anaemia management strategies for people taking boceprevir Liz Highleyman / 13 November 2012 Chronic hepatitis C patients treated with boceprevir (Victrelis) plus pegylated interferon and ribavirin can effectively manage drug-induced anaemia by either ribavirin dose reduction or addition of erythropoietin (EPO) without compromising treatment effectiveness, researchers ... Ribavirin dose reduction is effective for managing anaemia in patients using boceprevir or telaprevir Liz Highleyman / 11 May 2012 Reducing the dose of ribavirin and adding erythropoietin are both good options for managing anaemia in hepatitis C patients treated with boceprevir (Victrelis) triple therapy, according to study findings presented at the 47th ... ← First1Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive